Bone marrow transplantation in leukemia

References

• Jacobson LO, Simmons EL, Marks EK, et al. The role of the spleen in radiation injury and recovery. J Lab Clin Med 1950: 35(5): 746–70
   PubMed Web of Science ®Google Scholar
• Lorenz E, Uphoff D, Reid TR, et al. Modification of Irradiation injury in mice and guinea pigs by bone marrow Injections. J Natl Cancer Inst 1951: 12(1): 197–201
   PubMedGoogle Scholar
• Uphoff DE. Genetic factors influencing irradiation protection by bone marrow. I. The F1 hybrid effect. J Natl Cancer Inst 1957: 19(1): 123–30
   PubMedGoogle Scholar
• Uphoff DE, Law LW. Genetic factors Influencing irradiation protection by bone marrow. II. The histo-compatibility-2 (H-2) locus. J Natl Cancer Inst 1958: 20(3): 617–24
   PubMedGoogle Scholar
• Uphoff DE, Law LW. An evaluation of some genetic factors influencing irradiation protection by bone marrow. J Natl Cancer Inst 1959: 22(2): 229–41
   PubMedGoogle Scholar
• Gatti RA, Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968: 2(Dee 28): 1366–9
   Google Scholar
• Beutler E, McMillan R, Spruce W. The role of bone marrow transplantation in the treatment of acute leukemia in remission. Blood 1982: 59(6): 1115–7
   PubMed Web of Science ®Google Scholar
• Thomas ED, Clift RA, Buckner CD. Marrow transplantation for patients with acute nonlymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 1982: 66(7): 1463–6
   PubMedGoogle Scholar
• Buckner CD, Clift RA, Thomas ED, et al. Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. Leuk Res 1982: 6(3): 395–9
   PubMed Web of Science ®Google Scholar
• Clift RA, Buckner CD, Thomas ED, et al. Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using total body irradiation. Leuk Res 1982: 6(3): 409–12
   PubMed Web of Science ®Google Scholar
• Champlin R, Ho W, Arenson E, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. Blood 1982: 60(4): 1038–41
   PubMed Web of Science ®Google Scholar
• Skipper HE, Perry S. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. Cancer Res 1970: 30(Jun): 1883–97
   PubMed Web of Science ®Google Scholar
• Cline MJ, Haskell CM. Acute leukemia In: Cline MJ, Haskell CM, Cancer chemotherapy. 3rd ed. Philadelphia: WB Saunders. 1980: 244–50
   Google Scholar
• Schwarzenberg L, Mathé G. Twenty years of bone marrow grafting In the treatment of bone marrow leukemias and aplasias. Surg Clin North Am 1978: 58(3): 637–54
   PubMed Web of Science ®Google Scholar
• Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia: an analysis of factors associated with graft rejection. N Engl J Med 1977: 296(2): 61–6
   PubMed Web of Science ®Google Scholar
• Neiman PE, Reeves W, Ray G, et al. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 1977: 136(6): 754–67
   PubMed Web of Science ®Google Scholar
• Clift RA, Sanders JE, Thomas ED, et al. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 1978: 298(19): 1052–7
   PubMed Web of Science ®Google Scholar
• Weiden PL. Graft-versus host disease in allogeneic marrow transplantation. In: Gale RP, Fox CF, eds. Biology of bone marrow transplantation. New York: Harcourt Brace Jovanovich (Academic Press). 1980: 37–48
   Google Scholar
• Thomas ED. Bone marrow transplantation. In: Burchenal JH, Oettgen HF, eds. Cancer: achievements, challenges, and prospects for the 1980s. Vol 2. New York: Grune & Stratton. 1980: 630–8
   Google Scholar
• Lerner KG, Kao GP, Storb R, et al. Histocompatibility of graft-vs-host-reaction (GVHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974: 6(4)367–71
   PubMed Web of Science ®Google Scholar
• Ramsay NK, Kersey JH, Robison LL, et al. A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 1982: 306(7): 392–7
   PubMed Web of Science ®Google Scholar
• Powles RL, Clink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980: 1(8164): 327–9
   PubMed Web of Science ®Google Scholar
• Klintmalm GB, Iwatsuki S, Starzl TE. Nephro-toxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1981: 1(8218): 470–1
   PubMed Web of Science ®Google Scholar
• Weiden PL, Flournoy N, Thomas ED, et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979: 300(19): 1068–73
   PubMed Web of Science ®Google Scholar
• Weiden PL, Flournoy N, Sanders JE, et al. Anti-leukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc 1981: 13(1 Pt 1): 248–51
   PubMed Web of Science ®Google Scholar
• Weiden PL, Sullivan KM, Flournoy N, et al. Anti-leukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981: 304(25): 1529–33
   PubMed Web of Science ®Google Scholar
• Fialkow PJ, Thomas ED, Bryant JI, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971: 1(Feb 6): 251–5
   PubMed Web of Science ®Google Scholar
• Thomas ED, Bryant JI, Buckner CD, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1972: 1(Jun 17): 1310–3
   PubMed Web of Science ®Google Scholar
• Goh K, Klemperer MR. In vivo leukemic transformation: cytogenetic evidence of un vivo leukemic transformation of engrafted marrow cells Am J Hematol 1977: 2(3): 283–90
   PubMed Web of Science ®Google Scholar
• Elfenbein GJ, Brogaonkar DS, Bias WB, et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978: 52(3): 627–36
   PubMed Web of Science ®Google Scholar
• Newburger PE, Latt SA, Pesando JM, et al. Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Engl J Med 1981: 304(12): 712–4
   PubMed Web of Science ®Google Scholar
• Badger C, Buckner CD, Thomas ED, et al. Allogeneic marrow transplantation for acute leukemia in relapse. Leuk Res 1982: 6(3): 383–7
   PubMed Web of Science ®Google Scholar
• Thomas ED, Sanders JE, Flournoy N, et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 1979: 54(2): 468–76
   PubMed Web of Science ®Google Scholar
• Gale RP, Kay HE, Rimm AA, et al. Bone-marrow transplantation for acute leukaemia in first remission. Lancet 1982: 2(8306): 1006–8
   PubMed Web of Science ®Google Scholar
• Fefer A, Cheever MA, Thomas ED, et al. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. N Engl J Med 1979: 300(7): 333–7
   PubMed Web of Science ®Google Scholar
• Fefer A, Cheever MA, Greenberg PD, et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from Identical twins. N Engl J Med 1982: 306(2): 63–8
   PubMed Web of Science ®Google Scholar
• Clift RA, Buckner CD, Thomas ED, et al. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 1982: 2(8299): 621–3
   PubMed Web of Science ®Google Scholar
• McGlave PB, Hurd DD, Ramsay NK et al. Successful treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation. Exp Hematol 1982: 10(Suppl 11): 18
   Google Scholar
• Champlin RE, Gale RP. Allogeneic bone marrow transplantation for patients with chronic myelogenous leukemia (CML). Exp Hematol 1982: 10(Suppl 11): 19
   Google Scholar
• Clift RA, Hansen JA, Thomas ED. The role of HLA in marrow transplantation. Transplant Proc 1981: 13(1 Pt 1): 234–6
   PubMed Web of Science ®Google Scholar